| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Organogenesis Holdings (NASDAQ:ORGO) raises FY2025 Net product revenue outlook from $480.000 million-$510.000 million to $500.000 million-$525.000 million.
Posted In: ORGO